Glycosylation is one of the most common post-translational modifications in proteins, existing in about 50% of mammalian proteins. Several research groups have demonstrated that mass spectrometry is an efficient technique for glycopeptide identi- we present GlycoMID, a graph-based spectral alignment algorithm that can identify glycopeptides with multiple hydroxylysine O-glycosylation sites by tandem mass spectra. GlycoMID was tested on mass spectrometry data sets of the bovine collagen α-(II) chain protein, and experimental results showed that it identified more glycopeptidespectrum-matches than other existing tools, including many glycopeptides with two glycosylation sites.
Introduction
Glycosylation, existing in about 50% mammalian proteins, 1 plays vital roles in many cellular events, such as signal transduction and receptor activation, and is related to many diseases, including the congenital disorders of glycosylation and cancer. 2, 3 There has been increasing demand for techniques and bioinformatics tools for the identification and characterization of glycoproteins.
Glycans, which are attached to proteins (or lipids) in glycosylation, have many different compositions and structures, making the patterns of glycosylation extremely diverse. 2 Even for one specific glycosylation site, there are many glycans that can be attached to the site, which is called microheterogeneity. 4 As a result, it is a challenging problem to identify and characterize glycoproteins.
Mass spectrometry (MS) has been widely used for the identification of protein glycosylation because it is high throughput and capable of sequencing glycopeptides as well as decoding glycan structures. [5] [6] [7] In bottom-up MS-based glycosylation analysis, glycoproteins are first digested into short glycopeptides by a protease, and then the resulting glycopeptides are enriched and analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). 8, 9 Fragmentation methods in MS/MS determine the patterns of fragment ions observed in MS/MS spectra of glycopeptides. Collision-induced dissociation (CID) MS/MS spectra contain many glycosidic ions, which involve the breakage of glycan bonds; electron transfer dissociation (ETD) MS/MS spectra contain many ions with peptide backbone frag-mentation and intact glycosylation structures on the glycosylation sites; higher-energy collisional dissociation (HCD) MS/MS undergoes a similar process as CID, but results in a ladder of mono-, di-, or tri-saccharide oxonium ions and a dominated Y1 ion (peptide+GlcNAc) in spectra.
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The two main types of glycosylation are N-linked and O-linked glycosylation; other types of glycosylation include C-mannosylation, phosphoglycosylation, and glypiation. 13 N-linked glycosylation involves the attachment of glycans to asparagine or arginine residues, and Olinked glycosylation to serine, threonine, tyrosine, hydroxyproline, or hydroxylysine (HyK)
residues.
14 Moreover, N-glycans share a common core, GlcNAc2Man3, and follow biosynthetic pathways in extension; 15 O-glycan attachments have various types, such as glucose (Glc), galactose (Gal), mannose, and fucose.
13
Several studies have demonstrated that glycan structures can be successfully identified by LC-MS/MS. 16 There are three interconnected problems in analyzing a glycopeptide: determining the glycan structures, sequencing the peptide, and localizing the glycosylation sites.
Many software tools have been developed for the first problem, including SimGlycan, 17 GlycoWorkbench, 18 OSCAR, 19 GLYCH, 20 GlycosidIQ 21 and STAT. 22 Most of the tools were designed for the determination of the structures of N-glycans by using CID/HCD MS/MS spectra, which contain glycan fragment ions. There are also many software tools for the second and third problems, such as GlycoPep Grader 23 and GlycoPep Detector, 24 which utilize ETD MS/MS spectra that contain many peptide fragment ions. In addition, some software tools provide a solution to the three interconnected problems, including Peptoonist, 25 GlycoFragwork, 26 GlycoMaster DB, 27 Sweet-Heart, 28 MAGIC, 29 and the one proposed by Cheng et al. 30 In these tools, the first problem is solved by a de novo or glycan database search method, and the second and third problems by a peptide database search method.
However, the tools can analyze glycopeptides with only one glycosylation site due to the complexity of glycan structures.
In this study, we focus on a special O-linked glycosylation in which Gal or glucose- 
Methods

Mass spectrometry experiments
The protein collagen α-1 (II) (CO2A1) chain was acquired from bovine cartilage. 36, 37 Pepsinized immunization-grade bovine CO2A1 samples were prepared in either an ammonium bicarbonate buffer (ABC) or phosphate-buffered saline (PBS). The samples prepared in PBS were digested by GluC; the samples prepared in ABC were digested by either trypsin or GluC.
The digested peptides were subjected to LC-MS/MS analysis using a nano-LC system interfaced to an LTQ Orbitrap Velos TM mass spectrometer with a nano-ESI source. Two configurations of the mass spectrometer were used to acquire MS/MS data. For the first configuration, each full MS scan (resolution 15 000) was followed by CID and HCD MS/MS pair scans analyzing the 8 most intense ions in the MS scan, and the isolation width for collecting parent ions was set as 3 m/z. 
Collagen glycopeptide characterization problem
Unlike common glycosylation sites, O-linked glycosylation on collagen often involves only one or two monosaccharides (Gal or Glc-Gal). In addition, a peptide of collagen may contain multiple glycosylation sites. Because the glycans are short, an MS/MS spectrum of a collagen glycopeptide often contains both common fragment ions, such as b-and y-ions in CID/HCD spectra or c-and z • -ions in ETD spectra, and ions generated from a peptide bond cleavage and a glycosidic bond cleavage (Fig. 1) . 16,31,39 These ions provide enough information for simultaneous identification of glycosylation sites and glycan structures.
When an MS/MS spectrum is given and the unmodified form of the target peptide is known, the objective of glycosylation analysis is to find a glycoform (glycopeptide) of the peptide that best explains the spectrum. Because of the microheterogeneity of glycopeptides, there are many candidate glycoforms of the peptide whose molecular masses match the precursor mass of the spectrum. Since the number of candidate glycopeptides may be large, how to efficiently find the best glycoform is a challenging problem.
In the proposed algorithm, a peak counting score is used to evaluate glycopeptidespectrum-matches. The peak counting score between an experimental spectrum and a glycopeptide is the number of matched peak pairs (within an error tolerance) between the spectrum and the theoretical spectrum of the glycopeptide. We formulate the glycopeptide characterization problem on collagen as follows.
Collagen glycopeptide characterization problem Given an MS/MS spectrum, an unmodified peptide, and a number m, find a glycoform of the peptide with m monosaccharides that maximizes the peak counting score between the spectrum and the glycopeptide.
Representing the problem as a graph We will solve the glycopeptide characterization problem using a graph-based method. While both charge 1 and charge 2 ions were used for glycopeptide identification in the experiments, below only charge 1 ions are included to simplify the description of the proposed algorithm. In general, an MS/MS spectrum of a collagen glycopeptide is more complex than that of the unmodified form of the peptide because glycosidic bonds in glycans may be cleaved, increasing the complexity of the spectrum. The proposed method can be applied to CID, HCD and ETD MS/MS spectra. Here HCD MS/MS spectra are used to explain the method. To simplify the analysis, only band y-ions are included in the generation of theoretical spectra of glycopeptides. We further assume that monosaccharides in glycans have the same mass.
Let P = a 1 a 2 . . . a n be the unmodified form of a peptide and S an MS/MS spectrum of a glycoform of P with m monosaccharides. Let b i,j and y i,j be the m/z values of the singly charged b i and y i ions with j monosaccharides of the glycoform, respectively. We generate two (n − 1) × (m + 1) matching matrices B and Y by mapping b i,j and y i,j , for 1 ≤ i ≤ n − 1 and 0 ≤ j ≤ m, to the spectrum S ( Fig. 2(b) ). If b i,j (y i,j ) matches the m/z value of a peak
A directed graph containing n+1 layers is generated based on the matching matrices with three steps (Fig. 2(c) ). First, we generate n − 1 layers, each containing m + 1 nodes, in the middle of the graph. The jth node in the ith layer represents the prefix a 1 a 2 . . . a i of P with 
; the second considers both matching and supporting peaks:
, where α is a user-specified parameter for supporting peaks. Second, we add layer 0 and layer n. Each path from v 0,0 to v n,m corresponds to a glycoform of the peptide. For example, the heaviest path in Fig. 2 (c) corresponds to the glycopeptide AGFk(Gal)EGQk(Glc-Gal)GE that best explains the peaks in the spectrum ( Fig. 3(a) ). Compared with the best glycopep-tide, another candidate glycopeptide AGFk(Glc-Gal)EGQk(Gal)GE corresponds to a path with less weight (Fig. 2(c) ) and explains less peaks in the spectrum ( Fig. 3(b) ). When the theoretical spectrum of the glycoform contains only common b and y-ions with charge 1, the matching weight of the path equals the peak counting score between the glycoform and the spectrum. When the theoretical spectrum contains both common b and y-ions with charge 1 and those with glycosidic bond cleavages, the combined weight (α = 1) equals the peak counting score. As a result, the glycopeptide characterization problem is reduced to the heaviest path problem in the graph, which can efficiently solved by a dynamic programming algorithm. The number of operations of the algorithm is proportional to nm 2 , where n is the length of the peptide and m is the number of monosaccharides in the glycoform.
Database search In peptide identification, peptides are filtered by the precursor mass of the spectrum to speed up database search. Similarly, we use the precursor mass of the spectrum to filter peptides in glycopeptide identification. If the difference between the precursor mass of the spectrum and the molecular mass of a peptide matches the mass of a combination of allowed glycans (within an error tolerance), the peptide is chosen as a candidate. Each candidate peptide is aligned with the spectrum to find the best glycoform for it, and finally the best scoring glycoform among all candidate peptides is reported.
Results
We implemented GlycoMID in C++ and tested it on a desktop with an Intel Core i5 2.3 GHz dual-core CPU and 8 GB memory.
Glycopeptide identification
Proteome Discoverer version 1.4 (Thermo Scientific, San Jose, CA) was used to convert Thermo raw files to MGF files. Following the preprocessing steps in Ref. 7 , noise peaks were removed using a signal-to-noise ratio 1.5, and MS/MS spectra without peaks were removed.
After preprocessing, 12 908 CID, 13 186 HCD and 1 937 ETD MS/MS spectra were kept. In addition, the m/z values of the peaks were calibrated based on the differences between their experimental and theoretical m/z values. (See the supplementary material for details.)
In database searches, three types of post-translational modifications (PTMs) were set as variable PTMs: carbamidomethyl on cysteine, hydroxylysine, and hydroxyproline. [40] [41] [42] The error tolerance for precursor masses was set as 0.02 Da. Since the CID and ETD spectra were collected in the linear ion trap of the mass spectrometer, the error tolerance for CID and ETD fragment masses was set as 0.5 Da. The error tolerance for HCD fragment masses was also set as 0.5 Da so that the same parameter setting was used for the three types of spectra.
The protein database contained the peptides of CO2A1 protein and shuffled decoy peptides of the same size. Two approaches were used to estimate false discovery rates (FDRs) of identified peptide-spectrum-matches. In the first approach, peptide-spectrum-matches with or without glycosylation sites are combined to estimate FDRs. Using this approach Glyco-MID identified 4 081 spectra, including 1 901 CID, 1 809 HCD, and 371 ETD spectra, from 28 031 spectra with a 1% spectrum-level FDR. A total of 2 873 unmodified peptide-spectrummatches and 1 208 glycopeptide-spectrum-matches were identified, including 1 152 matches with one glycosylation site and 56 matches with two glycosylation sites. Of the matches with one glycosylation site, 605 contain one Gal and 547 contain one Glc-Gal. Of the matches with two glycosylation sites, 27 contain two Gals or two Glc-Gals, and 29 contain one Gal and one Glc-Gal. A total of 125 glycopeptides were identified, and the numbers of identified glycopeptides using HCD, CID, and ETD spectrum were 98, 84, and 70, respectively ( Fig. 4(a) ). In the second approach, we divided the identified peptide-spectrum-matches into three groups with 0, 1, or 2 glycosylation sites, and estimated FDRs of identified peptidespectrum-matches in the three groups separately. Using the second approach, GlycoMID identified 4 069 peptide-spectrum-matches (CID: 1 899, HCD: 1 825, and ETD: 345), including 2 872 matches without glycosylation, 1 122 matches with 1 glycosylation site, and 75 matches with 2 glycosylation sites, with a 1% spectrum-level FDR.
Coverage of the CO2A1 protein
The CO2A1 protein contains 68 lysine residues, of which 24 residues were identified as glycosylation sites by GlycoMID. By manual investigation, the residue K634 was removed from the list due to the low quality match, and the residue K781 was removed due to the ambiguity of the glycosylation site localization. Of the remaining 22 residues, the residue K929 was glycosylated with Glc-Gal only, and the other 21 were glycosylated with either Gal or Glc-Gal.
(See the supplementary material.) All the 22 residues are at the hydroxylysine positions of the Gly-Xaa-HyK motif, 36, 37, 43 and the glycosylation forms of the sites are consistent with a previous study. 7 The CO2A1 protein possesses 24 possible glycosylation sites with the Gly-Xaa-Hyk motif, including the 22 identified glycosylation sites. Of the remaining two sites, the site K773 was covered by identified peptides without glycosylation sites, and the site K1130 was not covered by any identified peptides. The MS/MS spectra of the peptides covering the site K1130 may lack enough fragment ion peaks, making them unidentifiable.
Because there are various glycosylated forms of the CO2A1 protein, the identified peptides may have different PTMs (including different glycans) on a glycosylation site. Two approaches were utilized to estimate the frequency that the CO2A1 protein has a PTM on a glycosylation site. The first approach is based on spectral counting. Let n 1 , n 2 , n 3 , n 4 be the numbers of identified spectra that support the unmodified lysine residue, the hydroxylysine residue, the hydroxylysine residue with a Gal, and the hydroxylysine residue with a Glc-Gal on a glycosylation site, respectively. The frequency of the unmodified lysine residue on the site is calculated as
, and those of other forms of modified residues are computed similarly. In the second approach, the intensity of the precursor ion of an MS/MS spectrum is treated as its weight, and the sums of the weights of the spectra that support the four forms of lysine residues are computed for the estimation.
The frequencies of the four forms of the residues on the 22 identified glycosylation sites and the site K773 are summarized in Table 1 . (See the supplementary material for details of the identified peptides.) K470 and K956 were mainly unmodified or hydroxylated; K287 was only hydroxylated or glycosylated; K299, K308, K374 and K803 were mainly hydroxylated or glycosylated; K731 was mainly glycosylated; K929 was only glycosylated with Glc-Gal.
After manual investigation, we found that most peptides covering K929 contain an oxidized methionine residue. Since this PTM was not included in the analysis, we only identified one form of the residue (the hydroxylysine residue with a Glc-Gal) on the site K929.
Comparison of the weight functions
We described two functions in Section "Methods" for assigning weights to nodes in the graph generated from the collagen glycopeptide characterization problem: the matching weight function and the combined weight function. We tested the two functions on all of the five data sets. Using a gradient method, we found that the combined weight function Excluding supporting peaks in the matching weight function will deteriorate its performance.
Fragment ions
Because Gal and Glc-Gal are short glycans, it is common to observe fragment ions with a loss of Gal or Glc-Gal. A fragment ion with only one Gal glycosylation site either keeps or loses the Gal. These two forms are called a Gal-ion and a Gal-loss ion, respectively. We computed the frequencies that Gal and Gal-loss ions were observed for b and y-ions with charge 1 or 2 in CID and HCD spectra and for c and z
• ions with charge 1 or 2 in ETD spectra, based on the 605 identified peptide-spectrum-matches with one Gal glycosylation site from 271 CID, 275 HCD, and 59 ETD spectra. (See Section "Glycopeptide identification.")
Below Gal b-ions with charge 1 in CID spectra are used to show how to compute the frequency. We generate all theoretical Gal b-ions with charge 1 from the identified glycopeptidespectrum-matches from CID spectra, and find the theoretical ions that are matched to an experimental peak in the corresponding spectrum. The frequency is computed as the ratio between the number of the matched theoretical ions and the total number of the theoretical ions.
Fig . 5 shows the frequencies of Gal and Gal-loss ions in CID, HCD, and ETD spectra.
While the ratio between the frequencies of Gal and Gal-loss ions in ETD spectra is about 7, those in CID and HCD spectra are about 1, supporting previous studies.
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Similarly, using spectrum-peptide matches with one Glc-Gal glycosylation site, the frequencies of fragment ions with a loss of Glc or Glc-Gal were obtained (Fig. 6 ). Compared with ETD spectra, HCD and CID spectra contain more fragment ions with a loss of Gal or Glc-Gal, which is consistent with previous findings: 44-49 CID tends to produce fragments of glycopeptides with minimal backbone fragmentation, and ETD tends to break glycopeptides along the peptide backbones, preserving glycans.
Due to the presence of prevalent glycan loss peaks in CID/HCD MS/MS spectra, GlycoMID might report glycopeptides with incorrect glycan compositions and glycosylation sites. To evaluate the performance of GlycoMID on the localization of glycosylation sites for CID/HCD MS/MS spectra with glycan loss peaks, we compared CID/ETD and HCD/ETD spectral pairs in the two data sets using HCD/CID/ETD alternate fragmentation. We analyzed the 36 CID/ETD and 41 HCD/ETD spectral pairs satisfying the condition that both the spectra were mapped to glycoforms of the same peptide that contains multiple lysine residues (candidate glycosylation sites), which may result in errors in the localization of glycosylation sites. Of these spectral pairs, 9 CID/ETD and 12 HCD/ETD spectral pairs reported different localization results. Manual inspection showed that most localization results reported by the 9 CID and 12 HCD spectra were not reliable because of the absence of key fragment ions with intact modifications.
Combination of CID, HCD and ETD MS/MS spectra
In the MS experiments, two data sets were generated using HCD/CID/ETD alternate fragmentation. The CID, HCD, and ETD spectra in these data sets were combined to improve glycopeptide identification. Using the combined spectra and the parameter settings described in Section "Glycopeptide identification," we identified 1 470 peptide-spectrum-matches, including 543 matches with glycosylation and 927 matches without glycosylation. Of the 1 470 matches, 171 matches with glycosylation and 163 matches without glycosylation were missed by peptide identification using single spectra (Fig. 7) . However, the combined approach also missed 111 peptide-spectrum-matches identified by single spectra. By manual inspection, we found that most of the 111 unidentified spectral triplets have only one high quality spectrum in the triplet.
Comparison with Mascot and X!Tandem
We compared GlycoMID and Mascot on the CO2A1 data sets. The input of Mascot was the same MGF files generated for GlycoMID. For Mascot, the error tolerances for precursor and fragment masses were set as 0.02 Da and 0.5 Da, respectively. Fixed and variable
PTMs as well as the fragment ions for scoring were set as the same to the analysis in Section "Glycopeptide identification." All the MS/MS spectra were searched against the targetdecoy concatenated peptide database used in Section "Glycopeptide identification." With a 1% spectrum level FDR, Mascot identified 3 531 spectra, of which 845 were matched to glycopeptides, A total of 91 glycopeptides were identified by Mascot, including 69, 63 and 38 glycopeptides from HCD, CID, and ETD MS/MS spectra, respectively (Fig. 4(b) ). All the glycopeptides identified by Mascot were also identified by GlycoMID, and GlycoMID identified more peptide-spectrum-matches than Mascot (Fig. 8) . While GlycoMID includes various fragment ions with and without glycan loss into the combined weight function, Mascot does not use all the fragment ions in the computation of similarity scores. That might be the main reason for the better performance of GlycoMID.
Although the scoring function of GlycoMID includes supporting peaks, it does not utilize the information of peak intensities. After manually inspection, we found out that CID and HCD MS/MS spectra contain more low-intensity noise peaks than ETD MS/MS spectra in the test data sets. These noise peaks were treated the same as high intensity signal peaks in the scoring function of GlycoMID. As a result, GlycoMID reported more decoy random glycopeptide-spectrum-matches for CID/HCD spectra than ETD ones. Because of these decoy matches, more CID/HCD target identifications of GlycoMID were filtered out than ETD target identifications with the same FDR. This might be the reason that the improvement of GlycoMID for CID/HCD spectra is less significant than that for ETD spectra. To further improve the performance of GlycoMID, a better scoring function should be designed to include both supporting peaks and patterns of the intensities of various fragment ion peaks. In addition, the performance of GlycoMID can be improved by using high accuracy and high resolution MS/MS spectra with small errors in the m/z values of fragment ion peaks.
The data sets were also analyzed using X!Tandem, which reported less identifications than
Mascot and GlycoMID. The data sets contain peptides with hydroxylation of lysine and two types of glycosylation of hydroxylysine residues, X!Tandem cannot handle three types of variable PTMs on the same amino acid residue, resulting in the miss of many identifications.
Discussion and conclusions
We proposed an algorithm GlycoMID for the identification of glycopeptides with O-linked glycosylation sites. The experiments on the CO2A1 data sets demonstrated that GlycoMID efficiently identified glycopeptides in the protein. Based the identified peptide-spectrummatches, a total of 22 lysine residue of CO2A1 were hydroxylated and glycosylated with Glc-Gal or Gal moieties, which is consistent with previous studies. We also showed that combining CID, HCD, and ETD spectra improved on the number of identified peptidespectrum-matched compared with single spectra.
A Because of the complexity of glycosylation and the similarity of glycoforms from the same peptide, multiple glycoforms with the same molecular mass may not be separately by LC, resulting in multiplexed MS/MS spectra of a mixture of the glycoforms. For such a spectrum, GlycoMID reports a glycoform with the highest similarity score, not multiple glycoforms.
Computational methods have been proposed for the identification of multiple proteoforms from a multiplexed spectrum in histone protein studies. 54,55 These methods can be applied to identify multiple glycoforms from a multiplexed MS/MS spectrum.
Supporting Information
The CO2A1 data sets are publicly available at MassIVE 
glucose: Figure 1 : Possible fragment ions generated from a glycopeptide AGFk(Glc-Gal)EGQKGE, in which k is a hydroxylysine residue. The matching matrices B and Y generated from the annotated spectrum. (c) A graph is generated based on the matrices B and Y using the combined weight function (α = 0.5). The heaviest path, shown in bold, corresponds to the glycoform AGFk(Gal)EGQk(Glc-Gal)GE. The path from layer 0 to layer 10 containing the blue subpath corresponds to the glycoform AGFk(Glc-Gal)EGQk(Gal)GE. The HCD MS/MS spectrum in Fig. 2(a) is annotated with fragment ions of glycopeptide AGFk(Gal)EGQk(Glc-Gal)GE, which corresponds to the heaviest path in Fig. 2(c) . (b) The same spectrum is annotated with fragment ions of glycopeptide AGFk(GlcGal)EGQk(Gal)GE, which corresponds to the path with the blue subpath in Fig. 2(c) with less weight. The peak in the shade area is annotated by AGFk(Gal)EGQk(Glc-Gal)GE, not by AGFk(Glc-Gal)EGQk(Gal)GE. Figure 6 : Frequencies of various fragment ions in the identified 547 glycopeptide-spectrummatches with only one Glc-Gal glycosylation sites, including 251 CID, 228 HCD, and 68 ETD spectra. Three types of fragment ions that contain only one glycosylation site with an Glc-Gal are compared: fragment ions keeping the Glc-Gal (Glc-Gal ions), losing the Glc (Glc-loss ions), and losing the Glc-Gal (Glc-Gal-loss ions). (a) Prefix fragment ions with charge 1 (b-ions for CID and HCD spectra and c-ions for ETD spectra). (b) Suffix fragment ions with charge 1 (y-ions for CID and HCD spectra and z
CID HCD ETD
• -ions for ETD spectra. (c) Prefix fragment ions with charge 2 (b-ions for CID and HCD spectra and c-ions for ETD spectra). (d) Suffix fragment ions with charge 2 (y-ions for CID and HCD spectra and z
• -ions for ETD spectra). Figure 8 : Comparison between the numbers of peptide-spectrum-matches reported by Mascot and GlycoMID with a 1% spectrum level FDR. (a-c) Glycopeptide-spectrum-matches identified from CID, ETD, and HCD spectra, respectively. (d-f) Peptide-spectrum-matches without glycosylation identified from CID, ETD, and HCD spectra, respectively.
